Skip to main navigation Skip to search Skip to main content

Single-sperm analysis for haplotype construction of de-novo paternal mutations: Application to PGD for neurofibromatosis type 1

  • G. Altarescu
  • , B. Brooks
  • , Y. Kaplan
  • , T. Eldar-Geva
  • , E. J. Margalioth
  • , E. Levy-Lahad
  • , P. Renbaum*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Background: Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder caused by mutations in the neurofibromin gene. Approximately, 50% of cases are caused by de-novo mutations. Even when the NF1 mutation is known, accuracy of PGD is highly enhanced by simultaneous analysis of linked markers. In a childless couple referred to PGD, the male carried a de-novo mutation, precluding the possibility of typing relatives to establish the mutation-associated haplotype. We developed a single-sperm haplotype analysis strategy to establish the haplotype linked to the NF1 mutation. Methods: Spermatozoa from freshly ejaculated semen were used as a substrate for multiplex PCR on single sperm. Results: In addition to the NF1 mutation, six informative polymorphic markers flanking the NF1 gene (D17S1294, D17S1849, D17S841, D17S975, NF1TG2 and NF1AC5) were linked to individual alleles in single sperm from the affected male. Conclusions: Single-sperm analysis established the haplotypes of both mutant and wild-type NF1 alleles and enabled the implementation of a PGD protocol using polymorphic marker analysis. This method is generally applicable to PGD for any disease in which the haplotype of paternal mutations cannot be determined by typing relatives.

Original languageEnglish
Pages (from-to)2047-2051
Number of pages5
JournalHuman Reproduction
Volume21
Issue number8
DOIs
StatePublished - Aug 2006

Keywords

  • NF1
  • PGD
  • Polymorphic markers
  • Single-sperm PCR

Fingerprint

Dive into the research topics of 'Single-sperm analysis for haplotype construction of de-novo paternal mutations: Application to PGD for neurofibromatosis type 1'. Together they form a unique fingerprint.

Cite this